Precision Medicine for Cardiac Resynchronization: Predicting Quality of Life Benefits for Individual Patients--An Analysis From 5 Clinical Trials [Original Articles]
Conclusions:
There is marked heterogeneity of treatment benefit of CRT that can be predicted based on baseline QoL, age, and QRS duration.
Source: Circulation: Heart Failure - Category: Cardiology Authors: Nassif, M. E., Tang, Y., Cleland, J. G., Abraham, W. T., Linde, C., Gold, M. R., Young, J. B., Daubert, J. C., Sherfesee, L., Schaber, D., Tang, A. S. L., Jones, P. G., Arnold, S. V., Spertus, J. A. Tags: Heart Failure, Quality and Outcomes Original Articles Source Type: research
More News: Cardiac Resynchronization Therapy | Cardiology | Clinical Trials | Heart | Heart Failure | Statistics